APA

Eisenhauer E. L., Zanagnolo V., Cohn D. E., Salani R., O'Malley D. M., Sutton G., Callahan M. J., Cobb B., Fowler J. M. & Copeland L. J. (20140929). A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer. : Gynecologic oncology.

Chicago

Eisenhauer Eric L, Zanagnolo Vanna, Cohn David E, Salani Ritu, O'Malley David M, Sutton Gregory, Callahan Michael J, Cobb Bobbi, Fowler Jeffrey M and Copeland Larry J. 20140929. A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer. : Gynecologic oncology.

Harvard

Eisenhauer E. L., Zanagnolo V., Cohn D. E., Salani R., O'Malley D. M., Sutton G., Callahan M. J., Cobb B., Fowler J. M. and Copeland L. J. (20140929). A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer. : Gynecologic oncology.

MLA

Eisenhauer Eric L, Zanagnolo Vanna, Cohn David E, Salani Ritu, O'Malley David M, Sutton Gregory, Callahan Michael J, Cobb Bobbi, Fowler Jeffrey M and Copeland Larry J. A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer. : Gynecologic oncology. 20140929.